Vaccines comprising enhanced antigenic helicobacter spp.
US5897475A · kind A · utility
10Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 1995 |
| Grant date | Apr 27, 1999 |
| Priority date | — |
| Expiry date | Oct 3, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods using in vitro processes are disclosed for inducing or enhancing expression of enteric bacterial antigens or virulence factors. The methods, therefore, produce antigenically enhanced enteric bacteria. Also methods for using the antigenically enhanced bacteria are also disclosed, as well as vaccines containing the enteric bacteria. Specifically, a whole enteric bacteria or components thereof are provided by Helicobacter species. Also there are other enteric bacteria which are useful for the disclosed invention; such as Campylobacter jejuni.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.